T 3761

Known as: T-3761 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1999
0119921999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
We investigated the extent of the binding of T-3761 to serum protein and obtained the following results. 1. The binding rates of… (More)
Is this relevant?
1995
1995
Absorption, distribution, excretion and metabolism were studied in rats and mice after oral and intravenous administration of 5… (More)
Is this relevant?
1995
1995
The effect of a new quinolone, T-3761, on the pharmacokinetics and metabolism of theophylline was investigated with rats. T-3761… (More)
Is this relevant?
1995
1995
Antigenicity studies of T-3761, a new quinolone derivative, were conducted and the following results were obtained. 1. By active… (More)
Is this relevant?
1995
1995
Phototoxicity and photoallergenicity tests of T-3761 (oral or percutaneous administration) were carried out in guinea pigs… (More)
Is this relevant?
1995
1995
We investigated cytotoxicity and mutagenicity of T-3761. The mutagenicity was evaluated using reverse mutation test with bacteria… (More)
Is this relevant?
1995
1995
We studied the absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals… (More)
Is this relevant?
1995
1995
Single dose toxicity studies of T-3761 were carried out in mice, rats and dogs, and the following results were obtained. 1. The… (More)
Is this relevant?
1993
1993
T-3761, a new quinolone derivative, showed broad and potent antibacterial activity. Its MICs for 90% of the strains tested were 0… (More)
Is this relevant?
1992
1992
The in vitro activity of T-3761, a new fluoroquinolone antimicrobial agent which has an oxazine ring structure with a cyclopropyl… (More)
Is this relevant?